Scientists identified a new compound called F6 that on testing in-vitro is potent against antibiotic-resistant pathogens such as MRSA, VRSA, and vancomycin-resistant Enterococcus (VRE), with vancomycin considered a drug of last resort. Tests indicate it is also less susceptible to resistance.

See the source article by following the link below:
Scientists identified a new compound called F6 that on testing in-vitro is potent against antibiotic-resistant pathogens such as MRSA, VRSA, and vancomycin-resistant Enterococcus (VRE), with vancomycin considered a drug of last resort. Tests indicate it is also less susceptible to resistance.